Hong Kong stocks movement | Kunbo Medical surged over 24% at one point, planning to repurchase up to 10% of its shares.

On December 13, Glonghui reported that Kubo Medical-B (2216.HK) increased against the trend today, rising by 24.53% to 0.66 Hong Kong dollars, reaching a new high since October 8. On the news front, Kubo Medical announced last night that it had resolved to recommend a share buyback, which will be financed from the company's existing available Cash, and it will not cause major adverse effects on the company's operating capital position. Up to approximately 52.72 million shares can be repurchased, accounting for 10% of the total shares issued on the day of the approved buyback resolution. This authorization will expire at the end of the company's next annual general meeting.

Gelonghui FinanceDec 13 10:05

Broncus to Repurchase Up to 10% of Issued Shares

MT NewswiresDec 12 19:08

Kunbo Medical-B (02216.HK): intends to repurchase shares in the market.

Gelonghui, December 12丨Kunbo Medical-B (02216.HK) announced that on December 12, 2024, the Board of Directors resolved to exercise the authority under the repurchase mandate to repurchase company shares from time to time on the open market. The proposed share repurchase will be funded using the company's existing available Cash / Money Market. The company will not conduct the repurchase if it would have a significant adverse effect on the company's working capital position. Subsequently, the company will cancel, hold as treasury shares, sell, or transfer repurchased shares (if any) as deemed appropriate by the Board of Directors. The company's current financial position is stable. The Board of Directors believes that the current Fill Price of the shares does not reflect their intrinsic value.

Gelonghui FinanceDec 12 16:50

Hong Kong stock concept tracking | Medical devices trade-in program attracts institutional attention, clear trend of market recovery.

"Trade-in" is accelerating in the field of medical devices, and various provinces are intensively issuing "feasibility announcements", "project approval announcements" and "tender procurement notices", injecting a dose of "cardiotonic" into the market.

Zhitong FinanceOct 29 09:30

Sudden Movement Spotlight | Biomedical Class B shares rose in the afternoon, LKYG-B up 30%, institutions bullish on sector further recovery space

Biomedical Class B shares rose in the afternoon, as of the time of publication, Lai Kai Medicine-B rose by 27.88%, to 7.89 Hong Kong dollars; YimingAngke-B rose by 17.91%, to 5.86 Hong Kong dollars; Yasheng Medicine-B rose by 5.74%, to 46.95 Hong Kong dollars.

Zhitong FinanceOct 17 14:04

There is no limit on price fluctuation, new stocks are being speculated! The pioneer of ultrasound submits an application for registration on the gem.

Cumulative dividends exceed 0.3 billion over 4 years.

Gelonghui FinanceOct 9 10:04